Retrospective Analysis Produced by Monarch Medical Technologies Explores the Effect of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks on Hypoglycemia Incidence
Two Posters Presented at AACE 2019 Review the Safety and Efficacy of Blood Glucose Goal Range and Two-Hour Blood Glucose Checks for Intravenous Insulin Dosing.
Bruce Lisanti, an experienced senior level executive in healthcare, technology and services industries, has been named president and chief executive officer of Monarch.
The complimentary webinar features Dr. Sandy Fogel of Carilion Clinic discussing glycemic management quality improvement in preparation for new quality metrics.
Monarch Medical Technologies Introduces New Online Community for Users of the EndoTool® Glucose Management System
Monarch Medical Technologies Appoints Expert in Pediatric Diabetes, Dr. Mark Vanderwel, to Medical Advisory Board
Monarch Medical Technologies adds Dr. Mark Vanderwel to medical advisory board to support company in advancing diabetes management for pediatric patients.